Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
Federal Trade Commission
US Army
Healthtrust
Daiichi Sankyo
Colorcon
Medtronic
McKinsey
Baxter

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,357,336

« Back to Dashboard

Which drugs does patent 7,357,336 protect, and when does it expire?


Patent 7,357,336 protects VARITHENA and is included in one NDA.

This patent has seventy patent family members in thirty-four countries.

Summary for Patent: 7,357,336

Title:Generation of therapeutic microfoam
Abstract: Improved therapeutic sclerosing microfoams and methods and devices for making them are provided that have advantage in producing a consistent profile injectable foam with minimal input by the physician yet using high volume percentages of blood dispersible gases, thus avoiding use of potentially hazardous amounts of nitrogen.
Inventor(s): Osman; Tariq (London, GB), Shilton-Brown; Sheila Bronwen (Brentwood, GB), Wright; David Dakin Iorwerth (High Wycombe, GB), Harman; Anthony David (Henley-on-Thames, GB), Boorman; Timothy David (Frinton on Sea, GB)
Assignee: BTG International Limited (London, GB)
Application Number:11/171,293
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Provensis
VARITHENA
polidocanol
SOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe A METHOD OF GENERATING AN INJECTABLE FOAM OF CONTROLLED DENSITY AND BUBBLE SIZE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,357,336

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9912356.4May 26, 1999

Non-Orange Book Patents for Patent: 7,357,336

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,091,801Generation of therapeutic microfoam► Subscribe
6,572,873 Generation of therapeutic microfoam► Subscribe
7,025,290Generation of therapeutic microfoam► Subscribe
7,604,185Generation of therapeutic microfoam► Subscribe
6,942,165 Generation of therapeutic microfoam► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,357,336

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina025530► Subscribe
Argentina027175► Subscribe
Argentina089412► Subscribe
Austria313317► Subscribe
Austria338807► Subscribe
Australia2005205772► Subscribe
Australia4939500► Subscribe
Australia4939700► Subscribe
Australia772515► Subscribe
Australia781642► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKinsey
US Department of Justice
Queensland Health
Deloitte
Fish and Richardson
Chinese Patent Office
AstraZeneca
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot